Dr. Tassa Saldi is an accomplished molecular biologist with more than 25 years of research experience in RNA biology, infectious disease, and molecular pathogen detection. Dr. Saldi graduated Summa Cum Laude with a degree in Molecular Biology. She completed her graduate and postdoctoral studies at the University of Colorado, where she studied RNA structure, small RNAs and RNA processing. She was awarded a prestigious fellowship from the American Cancer Society and was one of eighteen doctoral fellows nationwide invited to present her research at the Aspen Cancer Conference. Dr. Saldi has authored more than 20 peer-reviewed articles in top-tier journals. As the Chief Science Officer and co-founder of TUMI Genomics, Dr. Saldi continues to use her expertise to provide the cannabis industry with reliable, accurate diagnostic tools and pathogen mitigation guidance.
